Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

NCT03447028 is registered in ClinicalTrials.gov with Recep Tayyip Erdogan University Training and Research Hospital as lead sponsor.

NCT NCT03447028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03447028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index
Lead sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2007
Completion date
December 30, 2012
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome, prostate cancer